Strateg Iq Financial Group, LLC Eli Lilly & CO Transaction History

Strateg Iq Financial Group, LLC

$863 Million
Q4 2023

A detailed history of Strateg Iq Financial Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Strateg Iq Financial Group, LLC holds 4,993 shares of LLY stock, worth $3.89 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

4,993

Previous 4,992 0.02%

Holding current value

$3.89 Million

Previous $2.68 Million 8.54%

% of portfolio

0.34%

Previous 0.32%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 23, 2024	BUY	$525.19 - $619.13 $525 - $619	1 Added 0.02%	4,993 $2.91 Million
Q3 2023 Oct 19, 2023	SELL	$434.7 - $599.3 $36,080 - $49,741	-83 Reduced 1.64%	4,992 $2.68 Million
Q2 2023 Jul 17, 2023	BUY	$350.74 - $468.98 $10,872 - $14,538	31 Added 0.61%	5,075 $2.38 Million
Q1 2023 Apr 19, 2023	BUY	$310.63 - $364.82 $7,765 - $9,120	25 Added 0.5%	5,044 $1.73 Million
Q4 2022 Jan 12, 2023	BUY	$321.55 - $374.67 $30,547 - $35,593	95 Added 1.93%	5,019 $0
Q3 2022 Oct 21, 2022	BUY	$296.48 - $337.87 $592 - $675	2 Added 0.04%	4,924 $1.59 Million
Q2 2022 Jul 27, 2022	BUY	$278.73 - $327.27 $2,787 - $3,272	10 Added 0.2%	4,922 $1.6 Million
Q4 2021 Feb 04, 2022	BUY	$224.85 - $279.04 $167,063 - $207,326	743 Added 17.82%	4,912 $1.36 Million
Q3 2021 Nov 03, 2021	SELL	$221.6 - $272.71 $22,160 - $27,270	-100 Reduced 2.34%	4,169 $963,000
Q1 2021 May 04, 2021	SELL	$164.32 - $212.72 $16,432 - $21,272	-100 Reduced 2.29%	4,269 $798,000
Q4 2020 Jan 29, 2021	BUY	$130.46 - $172.63 $40,964 - $54,205	314 Added 7.74%	4,369 $738,000
Q3 2020 Nov 02, 2020	BUY	$146.22 - $169.13 $10,966 - $12,684	75 Added 1.88%	4,055 $600,000
Q1 2020 May 05, 2020	SELL	$119.05 - $147.35 $33,929 - $41,994	-285 Reduced 6.68%	3,980 $552,000
Q4 2019 Feb 03, 2020	BUY	$106.92 - $132.43 $55,491 - $68,731	519 Added 13.85%	4,265 $561,000
Q3 2019 Nov 01, 2019	BUY	$106.79 - $116.16 $28,833 - $31,363	270 Added 7.77%	3,746 $419,000
Q1 2019 Apr 26, 2019	SELL	$111.31 - $131.02 $22,262 - $26,204	-200 Reduced 5.44%	3,476 $451,000
Q3 2018 Oct 31, 2018	SELL	$85.86 - $107.31 $1,974 - $2,468	-23 Reduced 0.62%	3,676 $394,000
Q2 2018 Jul 25, 2018	SELL	$75.7 - $86.88 $15,140 - $17,376	-200 Reduced 5.13%	3,699 $316,000
Q2 2017 Aug 07, 2017	BUY	N/A	3,899	3,899 $321,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strateg Iq Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strateg Iq Financial Group, LLC with notifications on news.

Account

Strateg Iq Financial Group, LLC Eli Lilly & CO Transaction History